BBP (Virtus Biotech ETF) Stock Analysis - SEC Filings

Virtus Biotech ETF (BBP) is a publicly traded the market company. As of May 21, 2026, BBP trades at $90.21 with a market cap of $0 and a P/E ratio of 0.00. BBP moved +3.43% today. Year to date, BBP is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces BBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find BBP SEC filings?

Rallies organizes BBP SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

BBP Key Metrics

Key financial metrics for BBP
MetricValue
Price$90.21
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume140.02K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest BBP News

BBP Analyst Consensus

BBP analyst coverage data. Average price target: $0.00.

Common questions about BBP

Where can I find BBP SEC filings?
Rallies organizes BBP SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show BBP 10-K and 10-Q filings?
Rallies organizes BBP SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is BBP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BBP. It does not provide personalized investment advice.
BBP

BBP